{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:08:58Z","timestamp":1788520138839,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2022-I2M-2-002"],"award-info":[{"award-number":["2022-I2M-2-002"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-016"],"award-info":[{"award-number":["2021-I2M-1-016"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-047"],"award-info":[{"award-number":["2021-I2M-1-047"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-040"],"award-info":[{"award-number":["2021-I2M-1-040"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-017"],"award-info":[{"award-number":["2021-I2M-1-017"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-026"],"award-info":[{"award-number":["2021-I2M-1-026"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3602000"],"award-info":[{"award-number":["2022YFC3602000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230060"],"award-info":[{"award-number":["82230060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32141004"],"award-info":[{"award-number":["32141004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32441093"],"award-info":[{"award-number":["32441093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32430036"],"award-info":[{"award-number":["32430036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201978"],"award-info":[{"award-number":["82201978"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.coi.2025.102561","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T02:03:55Z","timestamp":1747015435000},"page":"102561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Can we cure rheumatoid arthritis?"],"prefix":"10.1016","volume":"94","author":[{"given":"Yi","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E","family":"Lipsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8775-1699","authenticated-orcid":false,"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102561_sbref1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2025.102561_bib2","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2025.102561_bib3","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheuma"},{"key":"10.1016\/j.coi.2025.102561_bib4","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102561_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard-2022-223134","article-title":"Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking","volume":"82","author":"Tang","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard-2022-223413","article-title":"American College of Rheumatology\/EULAR remission criteria for rheumatoid arthritis: 2022 revision","volume":"82","author":"Studenic","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib8","doi-asserted-by":"crossref","first-page":"e001220","DOI":"10.1136\/rmdopen-2020-001220","article-title":"DMARD-free remission as novel treatment target in rheumatoid arthritis: a systematic literature review of achievability and sustainability","volume":"6","author":"Verstappen","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.coi.2025.102561_sbref9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(23)02650-8","article-title":"Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial","volume":"403","author":"Rech","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2025.102561_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","article-title":"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"400","author":"Krijbolder","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2025.102561_bib11","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41588-018-0216-7","article-title":"Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes","volume":"50","author":"Westra","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102561_bib12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/annrheumdis-2021-221754","article-title":"Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset","volume":"81","author":"Saevarsdottir","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005370","article-title":"Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity","volume":"5","author":"Darrah","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2025.102561_bib14","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41423-022-00934-6","article-title":"A high-fiber diet synergizes with Prevotella copri and exacerbates rheumatoid arthritis","volume":"19","author":"Jiang","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.coi.2025.102561_sbref15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj1252","article-title":"Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset","volume":"10","author":"Hanlon","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.coi.2025.102561_bib16","article-title":"Single-cell sequencing of immune cells from anticitrullinated peptide antibody positive and negative rheumatoid arthritis","volume":"12","author":"Wu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2025.102561_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard-2022-223568","article-title":"Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis","volume":"82","author":"O'Neil","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib18","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/ard-2023-224479","article-title":"New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A\/F function","volume":"82","author":"Saviano","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/bjd\/ljac040","article-title":"Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials","volume":"188","author":"Langley","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2025.102561_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102561_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102947","article-title":"T cell aging as a risk factor for autoimmunity","volume":"137","author":"Liu","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2025.102561_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11926-023-01129-2","article-title":"Synovial tissue insights into heterogeneity of rheumatoid arthritis","volume":"26","author":"Jonsson","year":"2024","journal-title":"Curr Rheuma Rep"},{"key":"10.1016\/j.coi.2025.102561_bib23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41590-023-01527-9","article-title":"Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis","volume":"24","author":"Smith","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2025.102561_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41590-024-01774-4","article-title":"CD200(+) fibroblasts form a pro-resolving mesenchymal network in arthritis","volume":"25","author":"Rauber","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2025.102561_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41423-023-01108-8","article-title":"Metabolic reprogramming by Syntenin-1 directs RA FLS and endothelial cell-mediated inflammation and angiogenesis","volume":"21","author":"Meyer","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.coi.2025.102561_bib26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102561_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/annrheumdis-2020-218460","article-title":"Novel autoantibodies identified in ACPA-negative rheumatoid arthritis","volume":"80","author":"Li","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/annrheumdis-2013-204820","article-title":"Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using \u2076\u2078Ga-PRGD2 PET\/CT: a prospective proof-of-concept cohort study","volume":"73","author":"Zhu","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2025.102561_bib30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/rheumatology\/keae212","article-title":"Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies","volume":"64","author":"Heckert","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2025.102561_bib31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41584-024-01107-7","article-title":"Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis","volume":"20","author":"Chang","year":"2024","journal-title":"Nat Rev Rheuma"},{"key":"10.1016\/j.coi.2025.102561_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070856","article-title":"Therapeutic advances in rheumatoid arthritis","volume":"384","author":"Brown","year":"2024","journal-title":"Bmj"},{"key":"10.1016\/j.coi.2025.102561_bib33","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1136\/ard-2023-223977","article-title":"Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial","volume":"82","author":"Almayali","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_sbref34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ard-2024-225826","article-title":"Evaluation and prediction of relapse risk in stable systemic lupus erythematosus patients after glucocorticoid withdrawal (PRESS): an open-label, multicentre, non-inferiority, randomised controlled study in China","volume":"84","author":"Fei","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib35","article-title":"Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA)","volume":"11","author":"Singh","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coi.2025.102561_bib36","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S2665-9913(24)00021-3","article-title":"Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial","volume":"6","author":"Kj\u00f8rholt","year":"2024","journal-title":"Lancet Rheuma"},{"key":"10.1016\/j.coi.2025.102561_bib37","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/ard-2023-224476","article-title":"Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial","volume":"82","author":"Lillegraven","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib38","doi-asserted-by":"crossref","first-page":"e003029","DOI":"10.1136\/rmdopen-2023-003029","article-title":"Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study","volume":"9","author":"Kubo","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.coi.2025.102561_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1563-6","article-title":"Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study","volume":"20","author":"Zhou","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coi.2025.102561_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41573-024-00896-6","article-title":"The present and future of bispecific antibodies for cancer therapy","volume":"23","author":"Klein","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coi.2025.102561_sbref41","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41591-024-02964-1","article-title":"Bispecific T cell engager therapy for refractory rheumatoid arthritis","volume":"30","author":"Bucci","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2025.102561_bib42","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1200\/JCO.23.02329","article-title":"Durable responses with mosunetuzumab in relapsed\/refractory indolent and aggressive B-nell non-Hodgkin lymphomas: extended follow-up of a phase I\/II study","volume":"42","author":"Budde","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coi.2025.102561_bib43","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.2023023616","article-title":"Efficacy and safety of teclistamab in patients with relapsed\/refractory multiple myeloma after BCMA-targeting therapies","volume":"144","author":"Touzeau","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102561_bib44","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJMc2407150","article-title":"Teclistamab-induced remission in refractory systemic lupus erythematosus","volume":"391","author":"Alexander","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102561_bib45","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJMc2408786","article-title":"BCMA-targeted T-cell-engager therapy for autoimmune disease","volume":"391","author":"Hagen","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102561_bib46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.42415","volume":"75","author":"Buttgereit","year":"2023","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.coi.2025.102561_bib47","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0140-6736(23)01460-5","article-title":"Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"402","author":"Broome","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2025.102561_sbref48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102561_bib49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41422-024-01068-2","article-title":"Fourth-generation chimeric antigen receptor T-cell therapy is tolerable and efficacious in treatment-resistant rheumatoid arthritis","volume":"35","author":"Li","year":"2025","journal-title":"Cell Res"},{"key":"10.1016\/j.coi.2025.102561_bib50","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1016\/j.cell.2024.06.027","article-title":"Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.coi.2025.102561_bib51","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1474-4422(23)00194-1","article-title":"Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b\/2a study","volume":"22","author":"Granit","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coi.2025.102561_bib52","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/ard-2024-225785","article-title":"BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial","volume":"83","author":"Wang","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/annrheumdis-2020-217844","article-title":"In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells","volume":"80","author":"Zhang","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102561_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-023-03287-7","article-title":"Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials","volume":"14","author":"Lotfy","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.coi.2025.102561_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41584-024-01081-0","article-title":"Immune tolerance of citrullinated peptides","volume":"20","author":"Thomas","year":"2024","journal-title":"Nat Rev Rheuma"},{"key":"10.1016\/j.coi.2025.102561_bib56","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230209","article-title":"The CD4+ T cell repertoire specific for citrullinated peptides shows evidence of immune tolerance","volume":"220","author":"McElwee","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102561_bib57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.omtn.2022.12.008","article-title":"Chemically modified small interfering RNA targeting Hedgehog signaling pathway for rheumatoid arthritis therapy","volume":"31","author":"Lin","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.coi.2025.102561_bib58","article-title":"Peptide-oligonucleotide nanohybrids designed for precise gene therapy of rheumatoid arthritis","volume":"37","author":"Wang","year":"2025","journal-title":"Adv Mater"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525000378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525000378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:29:07Z","timestamp":1777782547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525000378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":58,"alternative-id":["S0952791525000378"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102561","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can we cure rheumatoid arthritis?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102561"}}